Page | Article - [Author(s)] | PDF | Abs. |
---|
One year in review |
---|
CER9567 2016,34,3,Suppl.97 Pg. 0001-0006 | One year in review: systemic vasculitis E. Elefante, A. Tripoli, F. Ferro, C. Baldini › Free to View |  |  |
Full Papers |
---|
CER8392 2016,34,3,Suppl.97 Pg. 0007-0011
| Posterior reversible encephalopathy syndrome and systemic vasculitis: report of six cases B. Lioger, E. Diot, M. Ebbo, N. Schleinitz, L. Aaron, J. Michot, O. Lambotte, R. Dhote, H. De Boysson, E. Ponce, F. Maillot; on behalf of the Société Nationale Française de Médecine Interne (SNFMI) and the CRI (Club Rhumatismes et Inflammation) |  |  |
|
CER8195 2016,34,3,Suppl.97 Pg. 0012-0015
| Immunogenetics of complement in mixed cryoglobulinaemia E. Menegatti, M. Messina, V. Oddone, E. Rubini, S. Sciascia, C. Naretto, S. Baldovino, D. Roccatello |  |  |
|
CER8427 2016,34,3,Suppl.97 Pg. 0016-0020
| Anaemia and low body mass index are associated with increased cardiovascular disease in patients with Takayasu arteritis Q. Liu, A. Dang, N. Lv, X. Wang, D. Zheng |  |  |
|
CER8526 2016,34,3,Suppl.97 Pg. 0021-0027
| The critical role of IL-6 in the pathogenesis of Takayasu arteritis X. Kong, Y. Sun, L. Ma, H. Chen, L. Wei, W. Wu, Z. Ji, L. Ma, Z. Zhang, Z. Zhang, Z. Zhao, J. Hou, S. Dai, C. Yang, L. Jiang |  |  |
|
CER8559 2016,34,3,Suppl.97 Pg. 0028-0032
| Hepatitis B virus causes mixed cryoglobulinaemia by driving clonal expansion of innate B-cells producing a VH1-69-encoded antibody M. Visentini, S. Pascolini, M. Mitrevski, R. Marrapodi, M. Del Padre, L. Todi, A. Camponeschi, E. Axiotis, M. Carlesimo, A. De Santis, M. Fiorilli, M. Casato |  |  |
|
CER8484 2016,34,3,Suppl.97 Pg. 0033-0039
| Epidemiology of Takayasu’s arteritis in Turkey M. Birlik, Y. Kücükyavas, K. Aksu, D. Solmaz, G. Can, A. Taylan, S. Akar, I. Sari, G. Keser, F. Onen, N. Akkoc |  |  |
|
CER8404 2016,34,3,Suppl.97 Pg. 0040-0043
| Association between histological features and clinical features of patients with biopsy positive giant cell arteritis K. Ting, S. Lester, E. Dunstan, C. Hill |  |  |
|
CER8694 2016,34,3,Suppl.97 Pg. 0044-0053
| Tocilizumab in patients with Takayasu arteritis: a retrospective study and literature review J. Loricera, R. Blanco, J. Hernández, S. Castañeda, A. Humbría, N. Ortego, B. Bravo, M. Freire, S. Melchor, M. Mínguez, J. Salvatierra, C. González-Vela, V. Calvo-Río, M. Santos-Gómez, T. Pina, M. González-Gay |  |  |
|
CER8967 2016,34,3,Suppl.97 Pg. 0054-0059
| Rituximab versus azathioprine for ANCA-associated vasculitis maintenance therapy: impact on global disability and health-related quality of life G. Pugnet, C. Pagnoux, B. Terrier, E. Perrodeau, X. Puéchal, A. Karras, C. Khouatra, O. Aumaître, P. Cohen, F. Maurier, O. Decaux, J. Ninet, P. Gobert, T. Quemeneur, C. Blanchard-Delaunay, P. Godmer, P. Carron, P. Hatron, N. Limal, M. Hamidou, M. Ducret, E. Daugas, T. Papo, B. Bonnotte, A. Mahr, P. Ravaud, L. Mouthon, L. Guillevin; for the French Vasculitis Study Group |  |  |
|
CER8281 2016,34,3,Suppl.97 Pg. 0060-0069
| Autoantibodies against lamin C, NA14 and CK15 in primary vasculitides or autoimmune diseases with secondary vasculitis B. Kubuschok, K. Preuss, K. Baier-Thoenes, E. Regitz, L. Thurner, G. Assmann, M. Pfreundschuh | 
 |  |
|
CER8988 2016,34,3,Suppl.97 Pg. 0070-0072
| Gender differences in giant cell arteritis: a case-control study A. Sturm, C. Dechant, F. Proft, H. Schulze-Koops, U. Hoffmann, M. Czihal |  |  |
|
CER9005 2016,34,3,Suppl.97 Pg. 0073-0076
| Plasma pentraxin-3 levels in patients with Takayasu’s arteritis during routine follow-up F. Alibaz-Oner, K. Aksu, S. Yentur, G. Keser, G. Saruhan-Direskeneli, H. Direskeneli |  |  |
|
CER8982 2016,34,3,Suppl.97 Pg. 0077-0083
| Late-onset IgA vasculitis in adult patients exhibits distinct clinical characteristics and outcomes
S. Hong, S. Ahn, D. Lim, B. Ghang, W. Yang, S. Lee, Y. Kim, C. Lee, B. Yoo |  |  |
|
CER9076 2016,34,3,Suppl.97 Pg. 0084-0088
| Interleukin 1 beta (IL1ß) rs16944 genetic variant as a genetic marker of severe renal manifestations and renal sequelae in Henoch-Schönlein purpura R. López-Mejías, F. Genre, S. Remuzgo-Martínez, B. Sevilla Pérez, S. Castañeda, J. Llorca, N. Ortego-Centeno, B. Ubilla, V. Mijares, T. Pina, V. Calvo-Río, J. Miranda-Filloy, A. Navas Parejo, D. Argila, J. Sánchez-Pérez, E. Rubio, M. Luque, J. Blanco-Madrigal, E. Galíndez-Aguirregoikoa, J. Martín, R. Blanco, M. González-Gay |  |  |
|
CER9106 2016,34,3,Suppl.97 Pg. 0089-0092
| Do vaccinations affect the clinical course of systemic necrotising vasculitis? A prospective observational web-based study S. Kernéis, C. Turbelin, C. Pagnoux, O. Launay, A. Mahr, L. Guillevin, P. Boëlle, T. Hanslik |  |  |
|
CER9231 2016,34,3,Suppl.97 Pg. 0093-0097
| Histopathologic differences between cutaneous vasculitis associated with severe bacterial infection and cutaneous vasculitis secondary to other causes: study of 52 patients J. Loricera, C. González-Vela, R. Blanco, J. Hernández, S. Armesto, M. González-López, V. Calvo-Río, F. Ortiz-Sanjuán, J. Val-Bernal, S. Hermana, A. Onaindia-Pérez, M. González-Gay |  |  |
|
CER9186 2016,34,3,Suppl.97 Pg. 0098-0104
| Neutrophil-related and serum biomarkers in granulomatosis with polyangiitis support extracellular traps mechanism of the disease M. Surmiak, M. Hubalewska-Mazgaj, K. Wawrzycka-Adamczyk, W. Szczeklik, J. Musiał, T. Brzozowski, M. Sanak |  |  |
|
CER9256 2016,34,3,Suppl.97 Pg. 0105-0110
| The relation between histopathological classification and renal outcome, ANCA subtype and treatment regimens in ANCA-associated vasculitis T. Kristensen, J. Gregersen, S. Krag, P. Ivarsen |  |  |
|
CER9243 2016,34,3,Suppl.97 Pg. 0111-0114
| Assessment of work limitations and disability in systemic vasculitis L. Barra, E. Bateman, S. Rohekar, C. Pagnoux, M. Moradizadeh |  |  |
Case Reports |
---|
CER8815 2016,34,3,Suppl.97 Pg. 0115-0120
| The transition of renal histopathology after immunosuppressive therapy in a woman with renal limited ANCA-associated vasculitis: a case report and literature review X. Li, Y. Liang, P. Pai |  |  |
Review |
---|
CER9414 2016,34,3,Suppl.97 Pg. 0121-0128 | Unsolved questions and concerns about treatment of anti-neutrophil cytoplasm antibody-associated vasculitides B. Chaigne, L. Guillevin › Free to View |  |  |
Paediatric Rheumatology |
---|
CER8614 2016,34,3,Suppl.97 Pg. 0129-0133
| Mortality in children with Kawasaki disease: 20 years of experience from a tertiary care centre in North India S. Singh, S. Bhattad, A. Gupta, D. Suri, A. Rawat, M. Rohit |  |  |
|
CER8652 2016,34,3,Suppl.97 Pg. 0134-0138
| Infliximab is the new kid on the block in Kawasaki disease: a single-centre study over 8 years from North India S. Singh, D. Sharma, D. Suri, A. Gupta, A. Rawat, M. Rohit |  |  |
|
CER8780 2016,34,3,Suppl.97 Pg. 0139-0144
| Incidence, epidemiology and clinical features of Kawasaki disease in Catalonia, Spain J. Sánchez-Manubens, J. Antón, R. Bou, E. Iglesias, J. Calzada-Hernandez; and the Kawasaki Disease in Catalonia Working Group |  |  |
Letters to the Editor |
---|
CER8095 2016,34,3,Suppl.97 Pg. 0145 | Pulmonary fibrosis in patients with positive neutrophil cytoplasmic antibodies vasculitis L. Tomàs Chaume, A. Martínez Escudé, V. Ortíz-Santamaria › Free to View |  |  |
|
CER8958 2016,34,3,Suppl.97 Pg. 0146 | Azathioprine-induced eosinophilic myocarditis in a patient with ANCA-associated vasculitis A. Berden, S. Beeres, S. Crobach, M. Schalij, T. Rabelink, Y. Teng › Free to View | 
 |  |